Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Revenue

In the year 2023, Edwards Lifesciences had annual revenue of $6.00B with 11.56% growth. Revenue in the quarter ending December 31, 2023 was $1.53B with 13.78% year-over-year growth.

• Revenue (ttm): $6.00B
• Revenue Growth: +11.56%
• P/S Ratio: 8.65
• Revenue / Employee: $303,273
• Employees: 19,800
• Market Cap: 51.97B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	6.00B	622.40M	11.56%
Dec 31, 2022	5.38B	149.90M	2.86%
Dec 31, 2021	5.23B	846.20M	19.29%
Dec 31, 2020	4.39B	38.30M	0.88%
Dec 31, 2019	4.35B	625.20M	16.79%
Dec 31, 2018	3.72B	287.50M	8.37%
Dec 31, 2017	3.44B	471.60M	15.91%
Dec 31, 2016	2.96B	470.00M	18.85%
Dec 31, 2015	2.49B	170.80M	7.35%
Dec 31, 2014	2.32B	277.40M	13.56%
Dec 31, 2013	2.05B	145.90M	7.68%
Dec 31, 2012	1.90B	221.00M	13.17%
Dec 31, 2011	1.68B	231.60M	16.01%
Dec 31, 2010	1.45B	125.60M	9.51%
Dec 31, 2009	1.32B	83.70M	6.76%
Dec 31, 2008	1.24B	146.60M	13.44%
Dec 31, 2007	1.09B	54.10M	5.22%
Dec 31, 2006	1.04B	39.10M	3.92%
Dec 31, 2005	997.90M	66.40M	7.13%
Dec 31, 2004	931.50M	71.00M	8.25%
Dec 31, 2003	860.50M	156.50M	22.23%
Dec 31, 2002	704.00M	11.90M	1.72%
Dec 31, 2001	692.10M	-111.70M	-13.90%
Dec 31, 2000	803.80M	-101.20M	-11.18%
Dec 31, 1999	905.00M	40.00M	4.62%
Dec 31, 1998	865.00M	-14.00M	-1.59%
Dec 31, 1997	879.00M	42.00M	5.02%
Dec 31, 1996	837.00M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.